Moderna inventory (NASDAQ: MRNA) has declined by about 25% during the last month and by near 17% during the last two buying and selling days alone. So what’s driving the sell-off? Firstly, rising bond yields have taken some sheen off development shares comparable to Moderna in current weeks. www.nasdaq.com
Moderna inventory (NASDAQ: MRNA) has declined by about 25% during the last month and by near 17% during the last two buying and selling days alone. So what’s driving the sell-off? Firstly, rising bond yields have taken some sheen off development shares comparable to Moderna in current weeks.
www.nasdaq.com